R. Scott Greer, Director at NEKTAR THERAPEUTICS (NKTR), sold 30,000 shares at $92.22 ($2.8M) on 2018-04-06, disclosed to the SEC on 2018-04-09.
Open-market sale of $2.8M NKTR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NKTR | SELL | 2018-06-06 | $603K | — | Filing → |
| SIEN | BUY | 2018-05-09 | $300K | — | Filing → |
| NKTR | BUY | 2016-10-25 | $203K | — | Filing → |